In Bulgaria, Entecavir is indicated in the treatment of chronic hepatitis B virus (HBV) infection in adults with:
- Compensated liver disease and evidence of active viral replication, persistently elevated serum alanine aminotransferase (ALT) levels and histological evidence of active inflammation and/or fibrosis.
- Decompensated liver disease
The product offers patients and doctors the opportunity to familiarize themselves with the Pharmascience brand which will set the ground for the upcoming launches in the upcoming months.
Pharmascience International Limited plans to focus on delivering high quality healthcare products to hospitals in Central and Eastern European regions. This would be done directly through its own brand, providing patients access to high quality products manufactured in Canada.